Wixela Inhub: Dosing Performance In Vitro and Inhaled Flow Rates in Healthy Subjects and Patients Compared with Advair Diskus

Lignende værker

• Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma
  af: Ng, Dik, et al.
  Udgivet: (2020)
• Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
  af: Allan, Richard, et al.
  Udgivet: (2021)
• Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies
  af: Haughie, Scott, et al.
  Udgivet: (2020)
• Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD
  af: Donohue, James F., et al.
  Udgivet: (2020)
• Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects
  af: Kirjavainen, Merja, et al.
  Udgivet: (2018)